Diabetes Ther (2019) 10(5):187992
In comparison to other GLP-1RAs, semaglutide was found to produce up to three times higher weight loss in type 2 diabetic patients and up to twice as much weight loss in obese patients, with some patients losing up to 15 kg
Reputation: Vendor reputation within research communities provides social proof of quality and reliability
28 However, when considering additional agents beyond metformin, it is important to first consider the patients ASCVD status
Song LJ, Luo H, Fan WH, Wang GP, Yin XR, Shen S, et al
If youve recently started taking GLP-1s, youre probably experiencing a lot of changes